New guidelines on preventing heart disease in women propose aspirin for all aged over 65

BMJ 2007; 334 doi: 10.1136/bmj.39140.415718.DB (Published 1 March 2007)
Cite this as: BMJ 2007;334:447.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Owen Dyer
  1. London

    New guidelines issued this week by the American Heart Association on the prevention of cardiovascular disease in women propose replacing the Framingham risk assessment method and adopting more aggressive preventive treatment of women who are currently considered at low risk.

    The guidelines, which were published online on 19 February in the American Heart Association's journal Circulation (http://circ.ahajournals.org, doi: 10.1161/circulationaha.107.181546), could lead to millions of women taking up low dose aspirin treatment. For the first time, the American Heart Association recommends considering low dose aspirin treatment in all women aged over 65 years, even those not classified as being at high risk.

    The Framingham risk function, derived from data gathered over two generations in the Massachusetts town of that name, has …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL